[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:telomere-reverse-transcriptase":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Telomere Reverse Transcriptase",6,[7,15,22,29,35,41],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07628972","Quercetin Dyskeratosis Congenita (DC)\u002FTelomere Biology Disorders (TBD)",[11],"Phase 1","RECRUITING","2026-08-26T02:15:45.413021Z","2026-06-06T00:48:49.540484Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT05271240","Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM",[19],"Phase 3","2026-08-26T02:17:04.346841Z","2026-05-05T02:43:29.020647Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":27,"content_modified":28},"NCT05463848","Surgical Pembro +\u002F- Olaparib w TMZ for rGBM",[26],"Phase 2","2026-08-03T03:33:28.152084Z","2026-05-05T02:43:28.879219Z",{"nct_id":30,"title":31,"phases":32,"status":12,"updated_at":33,"content_modified":34},"NCT04873102","Danazol for Treatment of Cytopenias in Patients With Cirrhosis",[26],"2026-08-26T02:19:31.671303Z","2026-05-05T02:43:28.646278Z",{"nct_id":36,"title":37,"phases":38,"status":12,"updated_at":39,"content_modified":40},"NCT06440850","Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation",[26],"2026-08-26T02:16:08.402952Z","2026-05-05T02:43:27.831863Z",{"nct_id":42,"title":43,"phases":44,"status":12,"updated_at":45,"content_modified":46},"NCT06817590","Nucleoside Therapy in Patients With Telomere Biology Disorders",[11],"2026-08-26T02:17:56.243868Z","2026-05-05T02:43:27.095750Z"]